检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]厦门大学附属第一医院药学部,厦门市361003
出 处:《临床合理用药杂志》2016年第20期7-10,共4页Chinese Journal of Clinical Rational Drug Use
摘 要:目的调查奥曲肽临床应用情况,评价其合理性,以促进临床合理用药。方法选取2015年1~12月医院使用奥曲肽的住院患者289例,对奥曲肽的用药指征、用法用量、疗程、停药指征等情况进行统计及分析。结果289份病例涉及12种用药指征,但均与消化系统疾病有关,用药剂量平均为(0.80±0.40)mg/d,疗程平均为(5.60±4.89)d,多以临床症状缓解、可进食流质为停药指征。结论临床应用奥曲肽过程中,其适应证、用量、疗程不适宜的现象普遍,需要采取相关措施进行规范,以保证患者用药的安全、有效、经济。Objective To investigate and evaluate the clinical application of Octreotide in order to promote its rational usage. Methods The medical records of 289 inpatients who were randomly selected from those taken Octreotide from January to December in 2015 were collected and analyzed to evaluate the rationality of usage from the aspects of indications,dosage,duration,withdrawal indication and so on. Results The reasons for application of Octreotide referred to twelve types of diseases,but all have related to disease of digestive system. The average dosage was 0. 80 ± 0. 40 mg / d,and the average duration was5. 60 ± 4. 89 d. When the clinical symptoms were relieved or patients could take fluid diet,Octreotide would be withdrawalled in mostly cases. Conclusion There were many differences between the clinical application and the introduction or documents of Octreotide in the aspects of indications,dosage,and duration and so on,and it needs to take some measures to promote the rational usage of Octreotide.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117